"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 6 | 2 | 8 |
| 1996 | 9 | 3 | 12 |
| 1997 | 12 | 3 | 15 |
| 1998 | 7 | 4 | 11 |
| 1999 | 18 | 8 | 26 |
| 2000 | 18 | 6 | 24 |
| 2001 | 13 | 11 | 24 |
| 2002 | 18 | 20 | 38 |
| 2003 | 22 | 15 | 37 |
| 2004 | 26 | 16 | 42 |
| 2005 | 30 | 16 | 46 |
| 2006 | 18 | 7 | 25 |
| 2007 | 16 | 12 | 28 |
| 2008 | 21 | 5 | 26 |
| 2009 | 6 | 9 | 15 |
| 2010 | 4 | 8 | 12 |
| 2011 | 2 | 11 | 13 |
| 2012 | 9 | 5 | 14 |
| 2013 | 7 | 6 | 13 |
| 2014 | 6 | 5 | 11 |
| 2015 | 6 | 9 | 15 |
| 2016 | 3 | 7 | 10 |
| 2017 | 4 | 5 | 9 |
| 2018 | 6 | 4 | 10 |
| 2019 | 3 | 10 | 13 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Integration of multiomic data identifies core-module of inherited-retinal diseases. Hum Mol Genet. 2025 Feb 17; 34(5):454-465.
-
Pharmacologic Blockade of a Pioneer Transcription Factor. Cancer Res. 2024 Dec 16; 84(24):4124-4125.
-
KAT tales: Functions of Gcn5 and PCAF lysine acetyltransferases in SAGA and ATAC. J Biol Chem. 2024 Oct; 300(10):107744.
-
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma. Sci Adv. 2024 May 31; 10(22):eadm9449.
-
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nat Commun. 2024 May 01; 15(1):3681.
-
Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages. PLoS One. 2024; 19(4):e0301904.
-
Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response. J Neuroinflammation. 2024 Jan 04; 21(1):11.
-
CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis. Nat Commun. 2023 06 03; 14(1):3220.
-
Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. J Neurooncol. 2023 Feb; 161(3):425-439.
-
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. Nat Commun. 2022 09 14; 13(1):5401.